Genentech
gene.com
Actively hiring
Health Care
Care Coordination & Population Health
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roche PharmExec
Three platform-technology deals paired Nanexa, Earendil Labs, and Atavistik Bio with Novo Nordisk, Genentech, and Roche to advance next-generation metabolic and oncology medicines.
Read more
Report
Genentech Breaks Ground On $750 Mln Manufacturing Expansion In Oregon For Drug Delivery Devices
Genentech, part of Roche Group, is expanding its Hillsboro, Oregon manufacturing facility with a $750 million investment to increase U.S. drug delivery device production capacity.
Read more
Report
Hanmi Pharm Terminates Belvarafenib Licensing Agreement... Genentech Returns Rights
Genentech, which had licensed Hanmi Pharmaceutical
Read more
Report
Hanmi reclaims belvarafenib rights as Genentech ends deal, Korea trial continues
Hanmi reclaims belvarafenib rights as Genentech ends deal, Korea trial continues Hanmi Pharmaceutical128940 will regain the rights to the targeted an
Read more
Report
Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregon
SOUTH SAN FRANCISCO, Calif., September 28, 2026--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), today broke ground on a $750 million expansion of its manufacturing facility in Hillsboro, Oregon, advancing plans announced in August to
Read more
Report
Genentech, Ionis Reveal Positive Interim Data From Phase III Sefaxersen Study In IgA Nephropathy
Genentech, affiliated to Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW), and partner Ionis Pharmaceuticals, Inc. (IONS) announced Wednesday positive prespecified interim results from the ongoing Phase III IMAgINATION study evaluating investigati
Read more
Report
Show more news